The US Food and Drug Administration (FDA) has voluntarily recalled 101 products made by Strauss Israel for potential contamination with Salmonella.
Elite chocolate, cakes, chewing gum, energy chocolate rice cakes, energy grain snacks, and wafers are among the products recalled by Strauss.
The Elite items were distributed to stores in California, Connecticut, Florida, New Jersey, and New York. Amazon, Fresh Direct, Passover.com, and other online stores have also carried kosher chocolates. The FDA's website has a complete list of the products that have been recalled.
The impacted chocolates and candies were created in a facility where Salmonella was discovered in both the liquid chocolate used in the goods and on production line equipment, according to the FDA. Customers who have purchased the products can return them for a full refund, and any merchant who carries them has been requested to remove them from the sale. In addition to the 101 products recalled in the US, the Canadian Food Inspection Agency (CIFA) has discovered 97 potentially contaminated products on the Canadian market.
According to the Strauss Group, they decided to act fully responsibly, not to take any risks, and remove all the factory products from the shelves.
The company also apologized to the Israeli public, customers, and retailers for the difficulty, while thanking them for their patience and vow9ng to get back to all inquiries.
The recall was initially limited to "more than a dozen types of chocolate and chocolate used as raw ingredients," but it was later expanded to include Elite-brand items. Two out of 270 chocolate goods tested positive for salmonella when Strauss tested samples from its plant. Since then, manufacturing at the company's plant has been temporarily halted.
According to the FDA, no illnesses have been linked to the recall in the United States. In Israel, 21 people who consumed the contaminated products developed symptoms that were compatible with salmonella, and the country's Health Ministry took samples from them.


Dow Hits Record High as Healthcare and Consumer Stocks Lead Wall Street Rally
Australia Urged to Simplify Regulations to Revive IPO Market and Boost Innovation
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground
Croatia Weighs Ante Zigman for Central Bank Governor Role in Key ECB Transition
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
S&P 500 Hits Record High as Tech Rally Slows Amid Iran Peace Uncertainty
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
European Stocks Rise as AI Optimism Offsets U.S.-Iran Tensions
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs 



